Health Canada has extended the validity of cannabis import permits and reduced the documentation applicants must provide for odour-control systems as part of a broader effort to streamline federal cannabis oversight.
The changes were announced Wednesday through a new online repository tracking revisions to cannabis and industrial hemp guidance documents.
Health Canada said the page will be updated regularly as its cannabis program reviews forms and guidance used by businesses applying for licences, maintaining existing licences and complying with the Cannabis Act and Cannabis Regulations.
Under one of the most significant changes, cannabis import permits may now remain valid for up to 12 months, compared with a previous maximum of six months.
The expiry date of a Canadian export permit will also be aligned with the expiration of the corresponding import permit issued by the receiving country. Health Canada classified the revision as a “key update,” meaning it may affect how regulated businesses understand or satisfy federal requirements.
Federal law generally restricts cannabis imports and exports to medical or scientific purposes.
Health Canada also revised its guidance covering cannabis odours and air-filtration systems.
Applicants must still have appropriate filtration systems in indoor cannabis production and storage areas, but they will no longer be expected to submit detailed plans or demonstrate the adequacy of those systems during the initial licensing process.
The requirement applies federally to indoor operations, although outdoor growers and other businesses may still be subject to provincial or municipal odour rules.
Several smaller revisions were also made to guidance for cannabis and industrial hemp licence holders.
Health Canada updated its industrial hemp licensing guide to clarify that a hemp licence alone does not authorize a business to mill flowering heads and turn the material into pellets. That activity requires a cannabis processing licence.
The agency also revised instructions for contacting its Industrial Hemp Unit. Email subject lines regarding an application must now include the applicant’s name, application identification number and the subject of the correspondence.
Additional wording changes were made to guidance covering products containing intoxicating cannabinoids other than delta-9 THC.
The updated document more clearly states that a licence holder’s preventive control plan must identify hazards associated with chemicals used to produce or synthesize cannabinoids, including potentially harmful chemical by-products, and establish appropriate measures to control those risks.
Other minor revisions clarified that the recommendations are intended for products formulated to contain intoxicating cannabinoids, rather than products containing only naturally occurring background levels.
Health Canada said the hemp and intoxicating-cannabinoid revisions were primarily editorial and intended to improve clarity rather than significantly change how compliance is assessed.
The federal government launched its broader Red Tape Reduction initiative in July 2025 with a stated focus on eliminating outdated or unnecessarily complicated processes, reducing regulatory overlap and improving service delivery.
Health Canada said the newly announced changes represent an early phase of the cannabis review, with additional revisions expected as more guidance documents and forms are examined.
Separate changes to Canada’s industrial hemp regulations may also be forthcoming. A federal consultation that concluded June 30 sought feedback on licensing, cultivation, THC testing, imports and exports, sales of flowering material, record keeping and other potential reforms intended to reduce administrative burdens on hemp producers.
The changes announced this week affect agency guidance and do not amend the Cannabis Act itself. Larger reforms requiring changes to federal law would generally need approval from Parliament.
The changes are part of a series of changes being put forth by Health Canada
Sponsors:
